Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
1832 Asset Management is a prominent Canadian investment firm that manages a broad range of public and private investment strategies. As a subsidiary of the Bank of Nova Scotia (Scotiabank), it operates several well-known investment brands, including Dynamic Funds and Scotia Funds. The firm provides asset management services to retail investors, institutional clients, and private wealth management platforms. While it may invest in life science and healthcare companies through its various mutual funds and portfolios, it is not a biotechnology or pharmaceutical company itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 1832 Asset Management.